The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Organs-on-Chips Market Outlook 2024
Synopsis
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
Global key players of Human Organs-on-Chips include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems and Draper Laboratory, etc. Top five players occupy for a share about 46%. North America is the largest market, with a share about 42%, followed by Asia-Pacific and Europe. In terms of product, Liver-on-a-chip is the largest segment, with a share over 28%. In terms of End User, Academic & Research Institutes is the largest market, with a share over 40%.
The global Human Organs-on-Chips market was valued at US$ 54 million in 2020 and is expected to reach US$ 142.6 million by the end of 2027, growing at a CAGR of 13.5% during 2021-2027.
This report focuses on Human Organs-on-Chips volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Human Organs-on-Chips market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Human Organs-on-Chips Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
Global key players of Human Organs-on-Chips include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems and Draper Laboratory, etc. Top five players occupy for a share about 46%. North America is the largest market, with a share about 42%, followed by Asia-Pacific and Europe. In terms of product, Liver-on-a-chip is the largest segment, with a share over 28%. In terms of End User, Academic & Research Institutes is the largest market, with a share over 40%.
The global Human Organs-on-Chips market was valued at US$ 54 million in 2020 and is expected to reach US$ 142.6 million by the end of 2027, growing at a CAGR of 13.5% during 2021-2027.
This report focuses on Human Organs-on-Chips volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Human Organs-on-Chips market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Human Organs-on-Chips Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Index1 Human Organs-on-Chips Market Overview
1.1 Product Overview and Scope of Human Organs-on-Chips
1.2 Human Organs-on-Chips Segment by Type
1.2.1 Global Human Organs-on-Chips Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Brain-on-a-chip
1.2.3 Liver-on-a-chip
1.2.4 Kidney-on-a-chip
1.2.5 Lung-on-a-chip
1.2.6 Heart-on-a-chip
1.2.7 Intestine-on-a-chip
1.2.8 Vessel-on-a-chip
1.2.9 Other Organs
1.3 Human Organs-on-Chips Segment by End User
1.3.1 Global Human Organs-on-Chips Sales Comparison by End User: (2021-2027)
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Cosmetics Industry
1.3.5 Others
1.4 Global Human Organs-on-Chips Market Size Estimates and Forecasts
1.4.1 Global Human Organs-on-Chips Revenue 2016-2027
1.4.2 Global Human Organs-on-Chips Sales 2016-2027
1.4.3 Human Organs-on-Chips Market Size by Region: 2016 Versus 2021 Versus 2027
2 Human Organs-on-Chips Market Competition by Manufacturers
2.1 Global Human Organs-on-Chips Sales Market Share by Manufacturers (2016-2021)
2.2 Global Human Organs-on-Chips Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Human Organs-on-Chips Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Human Organs-on-Chips Manufacturing Sites, Area Served, Product Type
2.5 Human Organs-on-Chips Market Competitive Situation and Trends
2.5.1 Human Organs-on-Chips Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Human Organs-on-Chips Players Market Share by Revenue
2.5.3 Global Human Organs-on-Chips Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Organs-on-Chips Retrospective Market Scenario by Region
3.1 Global Human Organs-on-Chips Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Human Organs-on-Chips Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Human Organs-on-Chips Market Facts & Figures by Country
3.3.1 North America Human Organs-on-Chips Sales by Country
3.3.2 North America Human Organs-on-Chips Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Human Organs-on-Chips Market Facts & Figures by Country
3.4.1 Europe Human Organs-on-Chips Sales by Country
3.4.2 Europe Human Organs-on-Chips Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Human Organs-on-Chips Market Facts & Figures by Region
3.5.1 Asia Pacific Human Organs-on-Chips Sales by Region
3.5.2 Asia Pacific Human Organs-on-Chips Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Human Organs-on-Chips Market Facts & Figures by Country
3.6.1 Latin America Human Organs-on-Chips Sales by Country
3.6.2 Latin America Human Organs-on-Chips Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Human Organs-on-Chips Market Facts & Figures by Country
3.7.1 Middle East and Africa Human Organs-on-Chips Sales by Country
3.7.2 Middle East and Africa Human Organs-on-Chips Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Human Organs-on-Chips Historic Market Analysis by Type
4.1 Global Human Organs-on-Chips Sales Market Share by Type (2016-2021)
4.2 Global Human Organs-on-Chips Revenue Market Share by Type (2016-2021)
4.3 Global Human Organs-on-Chips Price by Type (2016-2021)
5 Global Human Organs-on-Chips Historic Market Analysis by End User
5.1 Global Human Organs-on-Chips Sales Market Share by End User (2016-2021)
5.2 Global Human Organs-on-Chips Revenue Market Share by End User (2016-2021)
5.3 Global Human Organs-on-Chips Price by End User (2016-2021)
6 Key Companies Profiled
6.1 Emulate
6.1.1 Emulate Corporation Information
6.1.2 Emulate Description and Business Overview
6.1.3 Emulate Human Organs-on-Chips Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Emulate Human Organs-on-Chips Product Portfolio
6.1.5 Emulate Recent Developments/Updates
6.2 TissUse
6.2.1 TissUse Corporation Information
6.2.2 TissUse Description and Business Overview
6.2.3 TissUse Human Organs-on-Chips Sales, Revenue and Gross Margin (2016-2021)
6.2.4 TissUse Human Organs-on-Chips Product Portfolio
6.2.5 TissUse Recent Developments/Updates
6.3 Hesperos
6.3.1 Hesperos Corporation Information
6.3.2 Hesperos Description and Business Overview
6.3.3 Hesperos Human Organs-on-Chips Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Hesperos Human Organs-on-Chips Product Portfolio
6.3.5 Hesperos Recent Developments/Updates
6.4 CN Bio Innovations
6.4.1 CN Bio Innovations Corporation Information
6.4.2 CN Bio Innovations Description and Business Overview
6.4.3 CN Bio Innovations Human Organs-on-Chips Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CN Bio Innovations Human Organs-on-Chips Product Portfolio
6.4.5 CN Bio Innovations Recent Developments/Updates
6.5 Tara Biosystems
6.5.1 Tara Biosystems Corporation Information
6.5.2 Tara Biosystems Description and Business Overview
6.5.3 Tara Biosystems Human Organs-on-Chips Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Tara Biosystems Human Organs-on-Chips Product Portfolio
6.5.5 Tara Biosystems Recent Developments/Updates
6.6 Draper Laboratory
6.6.1 Draper Laboratory Corporation Information
6.6.2 Draper Laboratory Description and Business Overview
6.6.3 Draper Laboratory Human Organs-on-Chips Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Draper Laboratory Human Organs-on-Chips Product Portfolio
6.6.5 Draper Laboratory Recent Developments/Updates
6.7 Mimetas
6.6.1 Mimetas Corporation Information
6.6.2 Mimetas Description and Business Overview
6.6.3 Mimetas Human Organs-on-Chips Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mimetas Human Organs-on-Chips Product Portfolio
6.7.5 Mimetas Recent Developments/Updates
6.8 Nortis
6.8.1 Nortis Corporation Information
6.8.2 Nortis Description and Business Overview
6.8.3 Nortis Human Organs-on-Chips Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Nortis Human Organs-on-Chips Product Portfolio
6.8.5 Nortis Recent Developments/Updates
6.9 Micronit Microtechnologies B.V.
6.9.1 Micronit Microtechnologies B.V. Corporation Information
6.9.2 Micronit Microtechnologies B.V. Description and Business Overview
6.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Micronit Microtechnologies B.V. Human Organs-on-Chips Product Portfolio
6.9.5 Micronit Microtechnologies B.V. Recent Developments/Updates
6.10 Kirkstall
6.10.1 Kirkstall Corporation Information
6.10.2 Kirkstall Description and Business Overview
6.10.3 Kirkstall Human Organs-on-Chips Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Kirkstall Human Organs-on-Chips Product Portfolio
6.10.5 Kirkstall Recent Developments/Updates
6.11 Cherry Biotech SAS
6.11.1 Cherry Biotech SAS Corporation Information
6.11.2 Cherry Biotech SAS Human Organs-on-Chips Description and Business Overview
6.11.3 Cherry Biotech SAS Human Organs-on-Chips Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Cherry Biotech SAS Human Organs-on-Chips Product Portfolio
6.11.5 Cherry Biotech SAS Recent Developments/Updates
6.12 Else Kooi Laboratory
6.12.1 Else Kooi Laboratory Corporation Information
6.12.2 Else Kooi Laboratory Human Organs-on-Chips Description and Business Overview
6.12.3 Else Kooi Laboratory Human Organs-on-Chips Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Else Kooi Laboratory Human Organs-on-Chips Product Portfolio
6.12.5 Else Kooi Laboratory Recent Developments/Updates
7 Human Organs-on-Chips Manufacturing Cost Analysis
7.1 Human Organs-on-Chips Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Human Organs-on-Chips
7.4 Human Organs-on-Chips Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Human Organs-on-Chips Distributors List
8.3 Human Organs-on-Chips Customers
9 Human Organs-on-Chips Market Dynamics
9.1 Human Organs-on-Chips Industry Trends
9.2 Human Organs-on-Chips Growth Drivers
9.3 Human Organs-on-Chips Market Challenges
9.4 Human Organs-on-Chips Market Restraints
10 Global Market Forecast
10.1 Human Organs-on-Chips Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Human Organs-on-Chips by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Human Organs-on-Chips by Type (2022-2027)
10.2 Human Organs-on-Chips Market Estimates and Projections by End User
10.2.1 Global Forecasted Sales of Human Organs-on-Chips by End User (2022-2027)
10.2.2 Global Forecasted Revenue of Human Organs-on-Chips by End User (2022-2027)
10.3 Human Organs-on-Chips Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Human Organs-on-Chips by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Human Organs-on-Chips by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Human Organs-on-Chips Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Human Organs-on-Chips Sales (K Units) Comparison by End User (2021-2027)
Table 3. Global Human Organs-on-Chips Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Human Organs-on-Chips Covered in This Study
Table 5. Global Human Organs-on-Chips Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Human Organs-on-Chips Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Human Organs-on-Chips Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Human Organs-on-Chips Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Human Organs-on-Chips Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Human Organs-on-Chips Manufacturing Sites and Area Served
Table 11. Manufacturers Human Organs-on-Chips Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Human Organs-on-Chips by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Organs-on-Chips as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Human Organs-on-Chips Sales by Region (2016-2021) & (K Units)
Table 16. Global Human Organs-on-Chips Sales Market Share by Region (2016-2021)
Table 17. Global Human Organs-on-Chips Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Human Organs-on-Chips Sales by Country (2016-2021) & (K Units)
Table 19. North America Human Organs-on-Chips Sales Market Share by Country (2016-2021)
Table 20. North America Human Organs-on-Chips Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Human Organs-on-Chips Revenue Market Share by Country (2016-2021)
Table 22. Europe Human Organs-on-Chips Sales by Country (2016-2021) & (K Units)
Table 23. Europe Human Organs-on-Chips Sales Market Share by Country (2016-2021)
Table 24. Europe Human Organs-on-Chips Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Human Organs-on-Chips Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Human Organs-on-Chips Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Human Organs-on-Chips Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Human Organs-on-Chips Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Human Organs-on-Chips Revenue Market Share by Region (2016-2021)
Table 30. Latin America Human Organs-on-Chips Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Human Organs-on-Chips Sales Market Share by Country (2016-2021)
Table 32. Latin America Human Organs-on-Chips Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Human Organs-on-Chips Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Human Organs-on-Chips Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Human Organs-on-Chips Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Human Organs-on-Chips Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Human Organs-on-Chips Revenue Market Share by Country (2016-2021)
Table 38. Global Human Organs-on-Chips Sales (K Units) by Type (2016-2021)
Table 39. Global Human Organs-on-Chips Sales Market Share by Type (2016-2021)
Table 40. Global Human Organs-on-Chips Revenue (Million US$) by Type (2016-2021)
Table 41. Global Human Organs-on-Chips Revenue Share by Type (2016-2021)
Table 42. Global Human Organs-on-Chips Price (US$/Unit) by Type (2016-2021)
Table 43. Global Human Organs-on-Chips Sales (K Units) by End User (2016-2021)
Table 44. Global Human Organs-on-Chips Sales Market Share by End User (2016-2021)
Table 45. Global Human Organs-on-Chips Revenue (Million US$) by End User (2016-2021)
Table 46. Global Human Organs-on-Chips Revenue Share by End User (2016-2021)
Table 47. Global Human Organs-on-Chips Price (US$/Unit) by End User (2016-2021)
Table 48. Emulate Corporation Information
Table 49. Emulate Description and Business Overview
Table 50. Emulate Human Organs-on-Chips Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Emulate Human Organs-on-Chips Product
Table 52. Emulate Recent Developments/Updates
Table 53. TissUse Corporation Information
Table 54. TissUse Description and Business Overview
Table 55. TissUse Human Organs-on-Chips Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. TissUse Human Organs-on-Chips Product
Table 57. TissUse Recent Developments/Updates
Table 58. Hesperos Corporation Information
Table 59. Hesperos Description and Business Overview
Table 60. Hesperos Human Organs-on-Chips Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Hesperos Human Organs-on-Chips Product
Table 62. Hesperos Recent Developments/Updates
Table 63. CN Bio Innovations Corporation Information
Table 64. CN Bio Innovations Description and Business Overview
Table 65. CN Bio Innovations Human Organs-on-Chips Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. CN Bio Innovations Human Organs-on-Chips Product
Table 67. CN Bio Innovations Recent Developments/Updates
Table 68. Tara Biosystems Corporation Information
Table 69. Tara Biosystems Description and Business Overview
Table 70. Tara Biosystems Human Organs-on-Chips Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Tara Biosystems Human Organs-on-Chips Product
Table 72. Tara Biosystems Recent Developments/Updates
Table 73. Draper Laboratory Corporation Information
Table 74. Draper Laboratory Description and Business Overview
Table 75. Draper Laboratory Human Organs-on-Chips Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Draper Laboratory Human Organs-on-Chips Product
Table 77. Draper Laboratory Recent Developments/Updates
Table 78. Mimetas Corporation Information
Table 79. Mimetas Description and Business Overview
Table 80. Mimetas Human Organs-on-Chips Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Mimetas Human Organs-on-Chips Product
Table 82. Mimetas Recent Developments/Updates
Table 83. Nortis Corporation Information
Table 84. Nortis Description and Business Overview
Table 85. Nortis Human Organs-on-Chips Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Nortis Human Organs-on-Chips Product
Table 87. Nortis Recent Developments/Updates
Table 88. Micronit Microtechnologies B.V. Corporation Information
Table 89. Micronit Microtechnologies B.V. Description and Business Overview
Table 90. Micronit Microtechnologies B.V. Human Organs-on-Chips Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Micronit Microtechnologies B.V. Human Organs-on-Chips Product
Table 92. Micronit Microtechnologies B.V. Recent Developments/Updates
Table 93. Kirkstall Corporation Information
Table 94. Kirkstall Description and Business Overview
Table 95. Kirkstall Human Organs-on-Chips Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Kirkstall Human Organs-on-Chips Product
Table 97. Kirkstall Recent Developments/Updates
Table 98. Cherry Biotech SAS Corporation Information
Table 99. Cherry Biotech SAS Description and Business Overview
Table 100. Cherry Biotech SAS Human Organs-on-Chips Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Cherry Biotech SAS Human Organs-on-Chips Product
Table 102. Cherry Biotech SAS Recent Developments/Updates
Table 103. Else Kooi Laboratory Corporation Information
Table 104. Else Kooi Laboratory Description and Business Overview
Table 105. Else Kooi Laboratory Human Organs-on-Chips Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Else Kooi Laboratory Human Organs-on-Chips Product
Table 107. Else Kooi Laboratory Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Human Organs-on-Chips Distributors List
Table 111. Human Organs-on-Chips Customers List
Table 112. Human Organs-on-Chips Market Trends
Table 113. Human Organs-on-Chips Growth Drivers
Table 114. Human Organs-on-Chips Market Challenges
Table 115. Human Organs-on-Chips Market Restraints
Table 116. Global Human Organs-on-Chips Sales Forecast by Type (2022-2027) & (K Units)
Table 117. Global Human Organs-on-Chips Sales Market Share Forecast by Type (2022-2027)
Table 118. Global Human Organs-on-Chips Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 119. Global Human Organs-on-Chips Revenue Market Share Forecast by Type (2022-2027)
Table 120. Global Human Organs-on-Chips Sales Forecast by End User (2022-2027) & (K Units)
Table 121. Global Human Organs-on-Chips Sales Market Share Forecast by End User (2022-2027)
Table 122. Global Human Organs-on-Chips Revenue Forecast by End User (2022-2027) & (US$ Million)
Table 123. Global Human Organs-on-Chips Revenue Market Share Forecast by End User (2022-2027)
Table 124. Global Human Organs-on-Chips Sales Forecast by Region (2022-2027) & (K Units)
Table 125. Global Human Organs-on-Chips Sales Market Share Forecast by Region (2022-2027)
Table 126. Global Human Organs-on-Chips Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 127. Global Human Organs-on-Chips Revenue Market Share Forecast by Region (2022-2027)
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Organs-on-Chips
Figure 2. Global Human Organs-on-Chips Market Share by Type in 2020 & 2027
Figure 3. Brain-on-a-chip Product Picture
Figure 4. Liver-on-a-chip Product Picture
Figure 5. Kidney-on-a-chip Product Picture
Figure 6. Lung-on-a-chip Product Picture
Figure 7. Heart-on-a-chip Product Picture
Figure 8. Intestine-on-a-chip Product Picture
Figure 9. Vessel-on-a-chip Product Picture
Figure 10. Other Organs Product Picture
Figure 11. Global Human Organs-on-Chips Market Share by End User in 2020 & 2027
Figure 12. Pharmaceutical & Biotechnology Companies
Figure 13. Academic & Research Institutes
Figure 14. Cosmetics Industry
Figure 15. Others
Figure 16. Global Human Organs-on-Chips Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Human Organs-on-Chips Market Size 2016-2027 (US$ Million)
Figure 18. Global Human Organs-on-Chips Sales 2016-2027 (K Units)
Figure 19. Global Human Organs-on-Chips Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 20. Human Organs-on-Chips Sales Share by Manufacturers in 2020
Figure 21. Global Human Organs-on-Chips Revenue Share by Manufacturers in 2020
Figure 22. The Global 5 and 10 Largest Human Organs-on-Chips Players: Market Share by Revenue in 2020
Figure 23. Human Organs-on-Chips Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 24. Global Human Organs-on-Chips Sales Market Share by Region (2016-2021)
Figure 25. Global Human Organs-on-Chips Sales Market Share by Region in 2020
Figure 26. Global Human Organs-on-Chips Revenue Market Share by Region (2016-2021)
Figure 27. Global Human Organs-on-Chips Revenue Market Share by Region in 2020
Figure 28. United States Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Canada Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Germany Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. France Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. U.K. Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Italy Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Russia Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Japan Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. South Korea Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. India Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Australia Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. China Taiwan Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Indonesia Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Thailand Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Malaysia Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. UAE Human Organs-on-Chips Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Human Organs-on-Chips by Type (2016-2021)
Figure 51. Sales Market Share of Human Organs-on-Chips by End User (2016-2021)
Figure 52. Sales Market Share of Human Organs-on-Chips by End User in 2020
Figure 53. Revenue Share of Human Organs-on-Chips by End User (2016-2021)
Figure 54. Revenue Share of Human Organs-on-Chips by End User in 2020
Figure 55. Manufacturing Cost Structure of Human Organs-on-Chips
Figure 56. Manufacturing Process Analysis of Human Organs-on-Chips
Figure 57. Human Organs-on-Chips Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
